Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.
Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.